{"id":"https://openalex.org/W2017629401","doi":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","title":"An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure","display_name":"An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure","publication_year":1997,"publication_date":"1997-10-01","ids":{"openalex":"https://openalex.org/W2017629401","doi":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","mag":"2017629401","pmid":"https://pubmed.ncbi.nlm.nih.gov/9354315","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2042861"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2125.1997.t01-1-00586.x","doi":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.t01-1-00586.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.t01-1-00586.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108588442","display_name":"Frank O. M\u00fcller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":true,"raw_author_name":"F. O. M\u00fcller","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111865404","display_name":"M. V. Middle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"M. V. Middle","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075482338","display_name":"Robert Schall","orcid":"https://orcid.org/0000-0002-4145-3685","observed_orcids":["https://orcid.org/0000-0002-4145-3685"]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"R. Schall","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089477370","display_name":"J. Terblanch\u00e8","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"J. Terblanch\u00e9","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110324363","display_name":"Hans K. L. Hundt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"H. K. L. Hundt","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033786260","display_name":"Gerhard Groenewoud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I26999989","display_name":"University of the Free State","ror":"https://ror.org/009xwd568","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26999989"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"G. Groenewoud","raw_affiliation_strings":["FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FARMOVS Research Centre for Clinical Pharmacology and Drug Development, Department of Pharmacology, University of the Orange Free State, Bloemfontein, South Africa","institution_ids":["https://openalex.org/I26999989"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5108588442"],"corresponding_institution_ids":["https://openalex.org/I26999989"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.7863,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.85844859,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"44","issue":"4","first_page":"393","last_page":"398"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.07010000199079514,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.027799999341368675,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meloxicam","display_name":"meloxicam","score":0.9169999957084656},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":1.0},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8080000281333923},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.7739999890327454},{"id":"https://openalex.org/keywords/diuresis","display_name":"diuresis","score":0.7129999995231628},{"id":"https://openalex.org/keywords/sodium-excretion","display_name":"sodium excretion","score":0.7829999923706055},{"id":"https://openalex.org/keywords/serum-electrolytes","display_name":"serum electrolytes","score":0.7110000252723694},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.6940000057220459},{"id":"https://openalex.org/keywords/loop-diuretics","display_name":"loop diuretics","score":0.875},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.5130000114440918},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2779751750","wikidata":"https://www.wikidata.org/wiki/Q414028","display_name":"Meloxicam","level":2,"score":0.7338210344314575},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6763045191764832},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.6330685019493103},{"id":"https://openalex.org/C2777955127","wikidata":"https://www.wikidata.org/wiki/Q388801","display_name":"Furosemide","level":2,"score":0.5284119844436646},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4445878565311432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38834118843078613},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.37413910031318665},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32535791397094727}],"mesh":[{"descriptor_ui":"D000077239","descriptor_name":"Meloxicam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004573","descriptor_name":"Electrolytes","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005665","descriptor_name":"Furosemide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005665","descriptor_name":"Furosemide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013843","descriptor_name":"Thiazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1365-2125.1997.t01-1-00586.x","doi":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.t01-1-00586.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:9354315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9354315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:2042861","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2042861/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1046/j.1365-2125.1997.t01-1-00586.x","doi":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1997.t01-1-00586.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2125.1997.t01-1-00586.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017629401.pdf","grobid_xml":"https://content.openalex.org/works/W2017629401.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2068650875","https://openalex.org/W1992728863","https://openalex.org/W2009937287","https://openalex.org/W2413642610","https://openalex.org/W1975595108","https://openalex.org/W2189524939","https://openalex.org/W1981143907","https://openalex.org/W2413432297","https://openalex.org/W2409027245","https://openalex.org/W1494006892"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"evaluate":[2],"the":[3,85,91,127,135,160,166,172,176,193,203,219,227,239,249,284],"interaction":[4,297],"of":[5,71,96,99,126,134,165,171,175,185,218,226,268,280,286,298,305],"meloxicam":[6,49,100,299,306],"with":[7,11,18,300,311],"frusemide":[8,38,53,62,80,102,111,115,143,180,186,269,301,308],"in":[9,270],"patients":[10,17,34,44,76,86,310],"compensated":[12,23,312],"cardiac":[13,25,314],"failure.":[14,315],"METHODS:":[15],"Nineteen":[16],"Grade":[19],"II":[20],"or":[21,55,295],"III":[22],"chronic":[24,313],"failure":[26],"completed":[27],"this":[28],"randomized,":[29],"double-blind,":[30],"cross-over":[31],"study.":[32],"The":[33,94,121,213],"received":[35,45,77],"40":[36,51,60,78],"mg":[37,48,52,61,79],"day(-1)":[39,63,81],"for":[40,64,82,141,192,202,238,248],"7":[41,65,72,83],"days.":[42,66],"Thereafter,":[43],"either":[46],"15":[47],"plus":[50,59],"day(-1),":[54],"one":[56],"placebo":[57],"tablet":[58],"After":[67],"a":[68],"washout":[69],"period":[70,194,204,240,250],"days":[73],"during":[74],"which":[75],"days,":[84],"were":[87,144,187],"crossed":[88],"over":[89],"to":[90,147,151,156,190,200,236,246,263,275,309],"alternate":[92],"treatment.":[93],"effect":[95],"concomitant":[97],"ingestion":[98],"and":[101,107,113,139,153,197,243,307],"on":[103,210,256],"frusemide-induced":[104],"diuresis,":[105],"urine":[106],"serum":[108],"electrolytes,":[109],"urinary":[110,179,278],"excretion,":[112],"plasma":[114,142],"pharmacokinetics":[116],"was":[117,233],"also":[118],"determined.":[119],"RESULTS:":[120],"estimate":[122,161,214],"(90%":[123,162,215],"confidence":[124,163,216],"interval)":[125,164,217],"'(frusemide":[128,167,220],"+":[129,168,221],"meloxicam)/(frusemide":[130,169,222],"alone)'":[131,170,223],"mean":[132,173,224],"ratio":[133,174,225],"variables":[136,229],"Cmax,":[137],"AUC(SS)":[138],"Cmax/AUC(SS)":[140],"121%":[145],"(101%":[146,189],"145%),":[148],"106%":[149],"(96.4%":[150],"117%),":[152],"114%":[154],"(98.3%":[155],"132%),":[157],"respectively.":[158],"Similarly,":[159],"variable":[177],"cumulative":[178,230],"excretion":[181,232,279],"after":[182,207,253],"multiple":[183],"doses":[184],"123%":[188],"150%)":[191],"0-8":[195,241],"h,":[196],"122%":[198],"(105%":[199],"142%)":[201],"0-24":[205,251],"h":[206,242,252],"drug":[208,254],"administration":[209,255],"day":[211,257],"7.":[212,258],"pharmacodynamic":[228,296],"sodium":[231],"105%":[234],"(95.2%":[235],"116%)":[237],"108%":[244],"(96.5%":[245],"121%)":[247],"CONCLUSIONS:":[259],"Meloxicam":[260],"may":[261],"lead":[262],"slightly":[264,276],"increased":[265,277],"maximum":[266],"concentrations":[267],"plasma,":[271],"as":[272,274],"well":[273],"frusemide,":[281],"without":[282],"affecting":[283],"pharmacodynamics":[285],"frusemide.":[287],"Thus":[288],"there":[289],"is":[290],"no":[291],"clinically":[292],"significant":[293],"pharmacokinetic":[294],"following":[302],"repeated":[303],"co-administration":[304]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}